Evidence mapPaperPMID 41462096Full record

ArticleBMC cardiovascular disorders2025

C-reactive protein-to-albumin ratio as a novel prognostic biomarker for long-term mortality in pericarditis: a real-world study.

Lingyu Mi, Ishan Lakhani, Sharen Lee, Wing Tak Wong, Gary Tse, Fang Fang

Abstract read
In one paragraph

Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lingyu MiDepartment of Structural Heart Disease, Fuwai Hospital & National Center for Cardiovascular Disease, Key Laboratory of Innovative Cardiovascular Devices, Chinese Academy of Medical Sciences & Peking Union Medical College, National Health Commission Key Laboratory of Cardiovascular Regeneration Medicine, National Clinical Research Center for Cardiovascular Diseases, Beilishi Road No. 167, Xicheng District, Beijing, 100037, China.
Ishan LakhaniDepartment of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
Sharen LeeDepartment of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
Wing Tak WongSchool of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Gary TseSchool of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China. garytse86@gmail.com.
Fang FangDepartment of Structural Heart Disease, Fuwai Hospital & National Center for Cardiovascular Disease, Key Laboratory of Innovative Cardiovascular Devices, Chinese Academy of Medical Sciences & Peking Union Medical College, National Health Commission Key Laboratory of Cardiovascular Regeneration Medicine, National Clinical Research Center for Cardiovascular Diseases, Beilishi Road No. 167, Xicheng District, Beijing, 100037, China. fangfang_ff@hotmail.com.

Funding

Clinical and Translational Medicine Research Projects of CAMS 2023-I2M-C&T-B-057Key Technology Research and Device Development Project for Innovative Diagnosis and Treatment of Structural Heart Disease in the Southwest Plateau Region 202302AA310045National High Level Hospital Clinical Research Funding 2023-GSP-GG-34
6 · The paper itself

Abstract

backgroundPericarditis is a heterogeneous inflammatory condition with variable clinical outcomes. Although traditional inflammatory biomarkers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are routinely used for diagnosis and monitoring, they do not fully capture the interplay between inflammation, hepatic synthetic function, and nutritional status. The CRP–to–albumin ratio (CAR), a composite index integrating these components, has shown prognostic value in several cardiovascular disorders. However, its significance in pericarditis remains unknown.

methodsThis was a real-world retrospective cohort study of adult patients hospitalized for pericarditis between January 1st, 2005 to December 31st, 2019 from a single tertiary centre. CAR was calculated as CRP (mg/L) divided by serum albumin (g/L) and categorized into quartiles. The primary outcome was all-cause mortality. Associations were examined using Cox proportional hazards models, restricted cubic splines (RCS), and segmented Cox regression, with prespecified sensitivity analyses using alternative adjustment strategies and modeling specifications.

resultsA total of 546 patients (mean age, 59.2 ± 16.4 years; 56.8% men) were analyzed. During a median follow-up of 64 months, 239 deaths (43.8%) occurred. Higher CAR quartiles were associated with progressively increased mortality (log-rank P < 0.001). In multivariable Cox models adjusting for demographics and comorbidities, each unit increase in CAR conferred a 5% higher mortality risk (hazard ratio [HR], 1.05; 95% confidence interval [CI], 1.01–1.10; P = 0.031). Compared with the lowest quartile, adjusted HRs for mortality were 2.04 (95% CI, 1.34–3.09), 2.21 (95% CI, 1.47–3.32), and 1.93 (95% CI, 1.26–2.95) across quartiles 2–4 (P for trend = 0.004). RCS and segmented Cox analyses demonstrated a nonlinear relationship with a threshold near CAR = 0.33—below which mortality risk increased sharply and plateaued thereafter, which should be interpreted as exploratory given limited event density at very low CAR values. The overall association remained directionally consistent in sensitivity analyses including alternative knot specifications and approaches to address extreme values. Associations were consistent across age, sex, hypertension, and malignancy subgroups.

conclusionsCAR independently predicted long-term all-cause mortality in patients hospitalized for pericarditis, exhibiting a nonlinear dose–response pattern. CAR represents a simple, inexpensive, and readily available biomarker that integrates inflammatory and nutritional status, with robust findings across multiple sensitivity analyses, offering incremental prognostic value beyond traditional risk factors. C-REACTIVE PROTEIN-TO-ALBUMIN RATIO PREDICTS LONG-TERM ALL-CAUSE MORTALITY IN PERICARDITIS: Study design and main findings: higher CRP-to-albumin ratio is associated with increased long-term all-cause mortality in pericarditis

Indexed as

C-Reactive ProteinInflammation MediatorsPericarditisSerum Albumin, HumanAdultAgedBiomarkersCause of DeathFemaleHumansMaleMiddle AgedPredictive Value of TestsPrognosisRetrospective StudiesRisk AssessmentALB protein, humanBiomarkersC-Reactive ProteinInflammation MediatorsSerum Albumin, HumanAll-cause mortalityC-reactive protein–to–albumin ratioInflammationNutritional statusPericarditisPrognostic biomarkerRisk stratification

Identifiers

PMID41462096
PMCPMC12866473

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.